The Molecular Pages of the mesotelencephalic dopamine consortium (DopaNet) by Le Novère, Nicolas & Donizelli, Marco
BioMed  Central
Page 1 of 9
(page number not for citation purposes)
BMC Bioinformatics
Open Access Database
The Molecular Pages of the mesotelencephalic dopamine 
consortium (DopaNet)
Nicolas Le Novère* and Marco Donizelli
Address: Computational Neurobiology, EMBL-EBI, Wellcome-Trust Genome Campus, Hinxton Cambridge, CB10 1SD UK
Email: Nicolas Le Novère* - lenov@ebi.ac.uk; Marco Donizelli - maleko@ebi.ac.uk
* Corresponding author    
Abstract
Background:  DopaNet http://www.dopanet.org is a Systems Biology initiative that aims to
investigate precisely and quantitatively all the aspects of neurotransmission in a specific neuronal
system, the mesotelencephalic dopamine system. The project should lead to large-scale models of
molecular and cellular processes involved in neuronal signaling. A prerequisite is the proper storage
of knowledge coming from the literature.
Methods: DopaNet Molecular Pages are highly structured descriptions of quantitative parameters
related to a specific molecular complex involved in neuronal signal processing. A Molecular Page is
built by maintainers who are experts in the field, and responsible for the quality of the page content.
Each piece of data is identified by a specific ontology code, annotated (method of acquisition,
species, etc.) and linked to the relevant bibliography. The Molecular Pages are stored as XML files,
and processed through the DopaNet Web Service, which provides functionalities to edit the
Molecular Pages, to cross-link the Pages and generate the public display, and to search them.
Conclusions: DopaNet Molecular Pages are one of the core resources of the DopaNet project
but should be of widespread utility in the field of Systems Neurobiology.
Background
Although the use of Systems Biology to understand the
function of neurons recently started to gain momentum,
it is still in its infancy. A crucial step leading to meaningful
simulations is the reconstruction of large neuronal sys-
tems based on the elementary building blocks. However,
this approach suffers from the lack of truly quantitative
values. Some projects of functional genomics have been
recently launched to try to remedy the problem, e.g. the
Genes to Cognition consortium ([1,2]). Another problem
impairing the integration process resides in the large
diversity of protocols and model systems used to gather
the data. Since a large proportion of the data is potentially
shared by numerous different systems, it is sensible to
focus the effort on a restricted and well delineated system.
This approach has been pioneered by the Alliance for Cel-
lular Signaling, launched by Alfred Gilman ([3,4]), which
originally focused on the B-lymphocyte and the cardiac
myocyte.
DopaNet
Similarly, we started at the end of 2001 the mesotelen-
cephalic dopamine consortium (DopaNet, [5]). The initi-
ative aims to investigate precisely and quantitatively all
the aspects of neurotransmission – at the levels of the
molecule, the supra-molecular assembly, the neuronal
cell and the neuronal network – in a specific neuronal sys-
tem involved in many neuropathologies, such as
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Parkinson's disease, schizophrenia and drug addiction [6-
8]. The resulting integrated knowledge will not only pro-
vide relevant, up-to-date information about such pathol-
ogies, but will also form a firm substrate to link the
function of the neurobiological structures and the imple-
mentation of cognitive and mental abilities. As of June
2004, 35 European teams from 8 countries are part of the
project. DopaNet became a network of the European Sci-
ence Foundation (ESF) in January 2003.
A first step, prior to the design of large-scale dedicated
experiments, consists in data mining the current literature
in molecular and cellular neurobiology for existing quan-
titative knowledge. The resulting data has to be properly
stored and annotated.
DopaNet Molecular Pages
A DopaNet Molecular Page is a collection of annotated
numerical data relative to a "molecular complex" present
in one or several DopaNet target cells. The "molecular
complex" is taken here in the sense of the DopaNet Neu-
ronal Ontology (see below), as a "stable assembly of mol-
ecules", a "molecule" being described as a "set of atoms
linked together by covalent bounds". As a consequence,
we can have a Molecular Page storing data relative to a
molecular complex made up of components, that are
themselves described in other Molecular Pages. An antici-
pated example is an heterotrimeric G protein and its α and
βγ  subunits. The information collected deals with the
structure of the complex, its anatomical distribution
within DopaNet target cells, and its functional properties.
Each page is under the responsibility of its maintainer(s),
who decide which data is to be included or not, and
acknowledge the input of the various contributors. All the
data included in a Molecular Page is annotated (Species,
Methods, variability etc.), and linked to bibliographic ref-
erences. In addition, each single data stored in the data-
bases of DopaNet is attached to one or several terms of the
DopaNet Neuronal Ontology. This ontology will there-
fore act as a glue, relating the various pieces of data one to
the other.
DopaNet Neuronal Ontology
An ontology is defined here in its information science
meaning, as a hierarchical structuring of knowledge. In
our case, it is a relational vocabulary, that is a set of terms
linked together, aiming to describe a neuron. Each term
has a definition and a unique identifier. Terms are related
by "is a" inheritances, which represent sub-classing, and
"part of" inheritances which represent deepening knowl-
edge. For instance, the nicotinic receptor subunit alpha6
"is a" nicotinic receptor subunit, and is "part of" the
(alpha6)2(beta2)3 nAChR. Each term can be the child of
several others. Therefore the complete picture is not a
genealogical tree, but rather a network or relationships.
There are several biological ontologies, the most famous
(and complete) being Gene Ontology ([9,10]). Numerous
other projects can be found at repository of the Open Bio-
logical Ontologies ([11]). See the discussion below for the
relation between Gene Ontology and DopaNet Neuronal
Ontology. In DopaNet Neuronal Ontology, a "molecular
complex" is defined as a "stable assembly of molecules".
An obvious example of a molecular complex is a protein.
A molecular complex contains one or several compo-
nents. Those components are all "molecule", a molecule
being defined as a "set of atoms linked together by cova-
lent bounds". For instance, "(alpha4)_2(beta2)_3
nAChR" is a "nicotinic acetylcholine-gated receptor". It is
made up of two components: "alpha4 nicotinic receptor
subunit" and "beta2 nicotinic receptor subunit", that are
present in the "molecule" subtree as "nicotinic receptor
subunit". The "polypeptide" subtree of "molecule" is built
following the sequence resemblances, and then the 3D
structure, similarly to the Structural Classification Of Pro-
tein database ([12,13]) and InterPro ([14,15]). Contrary
to the "molecular complex" branch, the "molecule"
branch should not contain any group based on the
function.
Construction and content
Molecular page structure
A Molecular Page is made up of a header followed by sev-
eral lists, each list containing a sequence of identical ele-
ments. There are currently twelve main lists, described
below. Several other lists of items are used to described
the page data at a finer level. According to the molecular
complex described in the page, some of the lists can be
empty.
The Molecular Page header contains the name of the
molecular complex described in the page, an abbrevia-
tion, the unique ontology code used to identify the page,
the dates of creation and last modification of the page,
and the page status. The possible status are:
stable
The Molecular Page has been submitted by the maintain-
ers and is ready for public release.
unstable
A new version of the Molecular Page, not yet ready for
public release.
forthcoming
A new Molecular Page in construction, that has never been
submitted for public release.
For instance, the nicotinic acetylcholine receptor
(α4)2(β2)3 is described in the Page describing the complex
"(alpha4)_2(beta2)_3 nAChR" http://www.ebi.ac.uk/BMC Bioinformatics 2004, 5:174 http://www.biomedcentral.com/1471-2105/5/174
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compneur-srv/dopanet/MolecularPages/HTMLPages/
DA0000027.html. The related Ontology term can be
found at http://www.ebi.ac.uk/compneur-srv/dopanet/
Ontology/Terms/DA0000027.html
<molecularPage 
DopaNetontology="DA:0000027"
abbreviation="nAChRa4_2b2_3"
creation="2003-01-05T00:00:00"
modification="2004-09-
02T15:49:41"
name="(alpha4)_2(beta2)_3 
nAChR"
status="stable">
The main lists that compose a Molecular Page are:
List of maintainers
Maintainers are the only people authorized to directly
modify the Molecular Pages. They are responsible for the
quality and the completeness of the data included in the
Page. However, maintainers are not assumed to systemat-
ically gather the information all by themselves. They are
encouraged to contact experts to help them. Helpful peo-
ple should be acknowledged as contributors.
List of contributors
Contributors are all the people who bring new informa-
tion about a Molecular Page, or correct an existing piece of
information. Contributors can be seen as the equivalent
of authors of an article. Except maintainers (who are con-
tributors by definition), they cannot directly modify a
Molecular Page. They have to contact a maintainer
instead. Note that the database administration team can
directly modify the Molecular Pages to comply with the
guidelines.
List of components
A Molecular Page describes a molecular complex. This
complex is made up of components (at least one). The
listOfComponents describes those components, their sto-
ichiometry, and lists useful related resources. Each com-
ponent is annotated by its ontology code.
The complex "(alpha4)_2(beta2)_3 nAChR"
[DA:0000027] is made up of two components, the subu-
nit α4 and the subunit β2.
<listOfComponents>
<component DopaNetontology="DA:0000188"
name="alpha4 nicotinic receptor 
subunit"
stoichiometry="2">
<listOfResources>
<resource identifier="ACHa4hosa"
name="Ligand-Gated Ion Channel 
database"
references="1"
url="http://www.pasteur.fr/
recherche/banques/LGIC/">
<taxon>Homo sapiens</taxon>
</resource>
</listOfResources>
</component>
</listOfComponents>
List of states
The function of a molecular complex is most often mod-
ulated by permutations between various states (confor-
mational transitions, covalent modifications etc.).
Accordingly, most of the quantitative data are actually rel-
evant only for one state or a subset of states. Those states
should therefore be listed, described and annotated. The
quantitative data described in the "functional" lists (see
below) will refer both to the states of the molecular com-
plex itself, listed here, and the list of states of other rele-
vant Molecular Pages.
The complex "(alpha4)_2(beta2)_3 nAChR" may exist
under (at least) three different states: "basal", "active",
and "desensitized".BMC Bioinformatics 2004, 5:174 http://www.biomedcentral.com/1471-2105/5/174
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<listOfStates>
<state identifier="basal" 
name="basal">
<description>
In the basal state, the ionic poris 
closed. This state displays a weaaffinity 
for agonists such as acetylcho line or nic-
otine.
</description>
</state>
</listOfStates>
List of generic properties
A list of properties that depends solely on the molecular
complex itself, and not on its relationships with other
entities, such as ligands or substrates. Example of such
properties are molecular weight or Stoke radius.
<listOfGenericProperties>
<property name="MW" 
stateMolecule="basal">
<taxon>Homo sapiens</taxon>
<listOfValues>
<value mean="310971" 
unit="Dalton">
<comment>without covalent 
modifications.</comment>
</value>
</listOfValues>
</property>
</listOfGenericProperties>
List of cells
The distribution of the molecular complex and its compo-
nents is described within the relevant DopaNet target
cells: cortical glutamatergic pyramidal neuron, mesen-
cephalic dopaminergic neuron, striatal cholinergic
interneuron, striatal enkephalinergic/GABAergic medium
spiny neuron, striatal substance p/GABAergic medium
spiny neuron. It is likely that a listOfExtracellular shall be
necessary at some point.
Each cell is divided into compartments, where the distri-
bution of transcripts and molecules can be described. The
approach used to explore the distribution is specified,
since both the accuracy and the quantitativeness of the
observations strongly depends on the method chosen. As
for all the following data, the species where the study has
been conducted is also mandatory.
One entry in the complex "(alpha4)_2(beta2)_3 nAChR"
is the fact that in the cell soma of the rat mesencephalic
dopaminergic neuron, single cell RT-PCR experiments
showed that α4 is present in 100% of neurons and β2 is
probably also present in 100% of neurons.
<listOfCells>
<cell cellName="mesencephalic 
dopaminergic neuron"
DopaNetontology=" DA:0000702">
<listOfCompartments>
<compartment 
DopaNetontology="DA:0000137" 
name="cell soma">
<listOfTranscripts>
<transcript method="single cell 
RT-PCR" references="17">
<taxon>Rattus norvegicus
</taxon>
<description>
a4 is present in 100% of 
neurons. b2 is probably also present in 
100% of neurons.
</description>
</transcript>
</listOfTranscripts>
</compartment>
</listOfCompartments>
</cell>
</listOfCells>BMC Bioinformatics 2004, 5:174 http://www.biomedcentral.com/1471-2105/5/174
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List of ligands
The ligands of a molecular complex are molecules or ions
that bind to it. The size of the ligand relative to the molec-
ular complex is irrelevant. Within the Molecular Page of
"transforming growth factor receptor type I", one ligand is
"transforming growth factor betal". Conversely, in the
Molecular Page of "transforming growth factor beta1",
one ligand is "transforming growth factor receptor type I"!
See table 1 for an example of receptor-ligand reversion.
The endogenous ligands are identified by their ontology
code.
Functional parameters such as kon, koff or Km can be stored
in a controlled manner, in order to be easily retrieved
later. Whenever possible, the quantitative values are
related to the states of the molecular complexes involved,
not only the state of the molecular complex subject of the
Molecular Page but also the state of the ligand. This
remark holds for the substrates, the translocators and the
modulated substances as well (see below). See table 1 for
an illustration of the use of state references.
The desensitized "(alpha4)_2(beta2)_3 nAChR" of the rat
binds acetylcholine with a Ki versus the epibatidine of 8.6
± 1.98 nM.
<listOfLigands>
<ligand DopaNetontology="DA:0000184"
name="acetylcholine"
origin="endogenous">
<listOfProperties>
<property name="Ki_epibatidine"
references="10 18"
stateMolecule="desensitized">
<taxon>Rattus norvegicus</taxon>
<listOfValues>
<value mean="8.6" sd="1.98" 
unit="nanomole per litre"/>
</listOfValues>
</property>
</listOfProperties>
</ligand>
</listOfLigands>
List of substrates
All substances modified as a result of an interaction with
the molecular complex. The parameters stored here are for
instance Km, kcat or Vmax.
Table 1: Use of internal and external state references This example (in pseudocode for sake of compactness) shows the how the 
notions of receptor and ligand are relative to the current Molecular Page. It also makes use of internal and external links to the various 
states of the interacting complexes. Note that each interaction is coded twice, although the stateMolecule and stateLigand attributes 
are reversed. Internal links are in italic, while external links are underlined.
molecularPage name="mol1"
listOfStates
state identifier="greedy"
state identifier="neutral"
ligand name="mol2" stateLigand="active"
property name="Kd" stateMolecule="greedy"
value mean="10" unit="nanomole per litre"
property name="Kd" stateMolecule="neutral"
value mean="1" unit="micromole per litre"
molecularPage name="mol2"
listOfStates
state identifier="active"
state identifier="inactive"
ligand name="mol1" stateLigand="greedy"
property name="Kd" stateMolecule="active"
value mean="10" unit="nanomole per litre"
ligand name="mol1" stateLigand="neutral"
property name="Kd" stateMolecule="active"
value mean="1" unit="micromole per litre"BMC Bioinformatics 2004, 5:174 http://www.biomedcentral.com/1471-2105/5/174
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List of translocators
The translocators are substances that go from one subcel-
lular compartment to another, the translocation being
mediated by the molecular complex. Typical parameters
are conductance or relative permeability.
The active complex "(alpha4)_2(beta2)_3 nAChR" of the
rat translocates cations with a conductance of 13.3 ± 1.5
pS.
<listOfTranslocators>
<translocator 
DopaNetontology="DA:0000264"
name="cation"
origin="endogenous">
<listOfProperties>
<property name="conductance" 
references="14" 
stateMolecule="active">
<taxon>Rattus norvegicus</taxon>
<listOfValues>
<value mean="13.3" sd="1.5" 
unit="picosiemens"/>
</listOfValues>
</property>
</listOfProperties>
</translocator>
</listOfTranslocators>
List of modulated
In many case, one knows about the effect of a molecular
complex on a substance, without knowing the detailed
mechanism of action. The modulated  entries are to be
avoided as much as possible, since they generally reflect a
set of binding and/or enzymatic events.
List of transitions
Possible conversions between the states described in the
listOfStates, such as a conformational transition, or a cov-
alent modification.
The complex "(alpha4)_2(beta2)_3 nAChR" undergoes
conformational transitions between the basal and active
states.
<listOfTransitions>
<transition state 1="basal" 
state2="active">
<comment>
In the absence of lig 
and, the equilibrium is strongly displac-
etoward the basal state. Agonists, 
such aacetylcholine and nicotine, stabi-
lise thactive state and shift the equilib-
riumThe transition from basal to active 
corre sponds to an opening of the ionic 
pore.
</comment>
</transition>
</listOfTransitions>
List of bibitems
The list of bibliographic resources used to gather and
annotate the data. Each piece of data included in the
Molecular Page should be linked to those bibliographic
items by internal references.
Molecule Page storage
Molecular Pages are saved as XML files [16], and their
structure is described by an XML schema [17] available at
http://www.dopanet.org/MolecularPages/DopaN
etMP.xsd
Molecular Pages XML files are stored within two different
repositories, depending on the status of the Page. One
repository contains only the stable Pages ready for public
release (22 pages as of October 21, 2004), while the other
repository contains also the unstable and the forthcoming
Pages (39 pages as of October 21, 2004).
In addition to the two XML repositories, there is also a
third HTML repository, containing the human-readable
HTML versions of the stable Pages, automatically gener-
ated from their XML counterparts using XSL Transforma-
tions [18] with the Xalan processor [19]. Based on the
identifier attributes, this processing generates the links
within the Molecular Pages, but also between different,
although related, Molecular Pages.BMC Bioinformatics 2004, 5:174 http://www.biomedcentral.com/1471-2105/5/174
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Processing
As described above, Molecular Pages are continuously
modified and updated by the maintainers, with the help
of the contributors. In order to automatize, safe-guard and
simplify as much as possible the work required by a main-
tainer to create and edit a Molecular Page, an application
called the DopaNet Web Service has been designed and
implemented, which provide functionalities to:
1. authenticate Page maintainers
2. browse pages by maintainers
3. grant exclusive Page editing rights to a maintainer
4. create and edit a Page via a rich user interface
5. save or submit the edited Page, setting the "stable/
unstable" status
The DopaNet Web Service is made of both server-side and
client-side components, all written in Java, and communi-
cating via either the SOAP [20] or the HTTP protocol. The
server is deployed into an Apache Tomcat server [21],
while the clients are both a Java Applet and a collection of
dynamic (Java Server Pages) and static (HTML) pages. The
Applet provides a very rich interface to edit a Molecular
Page, but due to the Applet technology limitations (secu-
rity sandbox, download time, etc.), a form-based HTML
Page editor is current under development. Most of the
Applet and the HTML editor components are derived
directly from the DopaNet Molecular Page XML schema,
using a mapping between XML schema types and Java
GUI or HTML form widgets. Both server- and client-side,
Molecular Page XML data is handled using Apache tools
such as the Xerces parser [22] and the Xalan processor.
In addition to support the remote creation and editing of
Molecular Pages, the DopaNet Web Service provide also
functionalities to:
1. register new DopaNet contributors
2. update existing DopaNet contributor information
3. browse Molecular Pages by status
4. search Molecular Pages
Searching of Molecular Pages is implemented by using the
API provided by the Apache Xindice [23] native XML data-
base, which has proved to be adequate in terms of speed
for the amount of data we currently have in DopaNet.
Utility and discussion
Although in their early stage of development, DopaNet
Molecular Pages provide a unique source of structured,
annotated quantitative data about the molecules involved
in neuronal signaling. They will feed both the experimen-
tal biologist and the theoretician with the best available
estimates for all kind of knowledge, whether biochemical,
anatomical or functional. This will allow them to design
better experiments or formal models, and to benchmark
their results. As a side-effect triggered by the mandatory
annotations, DopaNet Molecular Pages will also a biblio-
graphic resource, each page being the equivalent of a
small review of the literature.
DopaNet Neuronal Ontology
Gene Ontology is now a fully grown project, and is being
widely used in several biological domains. Nevertheless,
in its present form, Gene Ontology was not found suitable
to be directly used by the DopaNet project. We hope to
collaborate with Gene Ontology maintainers in the
future. In particular, effort will be made to complete Gene
Ontology in the area of Neurobiology. However,
DopaNet Neuronal Ontology will never actually be a sub-
set of Gene Ontology. Indeed, the purpose of the latter is
to classify the gene products – and one of its most useful
application so far has been the annotation of sequence
database entries. The purpose of DopaNet Ontology is
broader in term of knowledge, and not limited to the clas-
sification of gene products. At the same time it is focused
onto a specific system, and therefore of interest for a nar-
rower audience.
The Gene Ontology consortium defined three different
vocabularies molecular function, biological process, and cellu-
lar component. Only the latter is at the moment relevant to
DopaNet purposes, that is the Molecular Pages. However,
it is anticipated that the biological process vocabulary will
be needed in the near future, for instance to annotate elec-
trophysiological data. DopaNet cellular component vocab-
ulary is larger than Gene Ontology one, since it contains
the different kinds of neuronal cells (see the Cell Type
ontology [24]) In addition, one can foresee the need of
other types of vocabularies to handle more integrated
information such as mutant phenotypes, for instance
Molecular function or vocabularies dealing with behaviors
(other efforts have already started in that direction, see for
instance the Mammalian Phenotype Ontology, ([25]).
A cellular component may be for instance an anatomical
structure, e.g. "dendrite" or "synaptic vesicle" but also a
cell or a protein. Note that a "molecule" is defined in the
Neuronal Ontology as a set of atoms covalently linked. A
molecule cannot contains other molecules. Hence, a pro-
tein made up of several subunits, or a polypeptide and a
co-enzyme are not "molecules", but "molecular com-BMC Bioinformatics 2004, 5:174 http://www.biomedcentral.com/1471-2105/5/174
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plexes". Although our ontology is built for DopaNet pur-
poses, it can be viewed as a more general "Neuronal
Ontology". Therefore, we incorporate terms related to
components present (or events taking place) in any neu-
ron, not necessarily DopaNet target cells. In particular,
such additions are advised if they clarify some hierarchical
relationship.
As described above, a "molecular complex" in DopaNet
Neuronal Ontology contains one or several components,
also present in the "molecule" branch. It could be consid-
ered redundant that all monomeric proteins are repre-
sented by two terms, as a "molecule" part of a "molecular
complex". However, the meanings of the two branches are
different. The "molecule" can be seen as an ideal entity,
while the latter would rather represent an actual physical
object of the cell. Moreover, the hierarchical structures of
the two branches are different. In addition, a lot of
proteins have only recently been discovered as functional
complexes (e.g. the polymeric G-protein coupled recep-
tors), and more are to be discovered. Finally, the system-
atic dissociation between the functional molecular
complex and its components is handy when it comes to
write the Molecular Pages.
Molecular Pages
The Alliance for Cellular Signaling was a pioneer in
designing Molecule Page. Contrary to DopaNet Molecular
Pages, their focus is truly a "molecule" rather than a
"molecular complex". For instance, an heteropolymeric
receptor will not be represented by a Molecule Page, but
rather by a collection of Pages, one per subunit.
DopaNet Molecular Pages are highly structured. While
this could appear as an obvious choice, it actually comes
with a double burden. First, the edition interface has to be
sufficiently complex to reflect the underlying structure.
This complexity certainly acts as a repellent for the biolo-
gist who wish to build a Molecular Page. Second, the high
quality required, in particular concerning the annota-
tions, leads to the rejection of a significant portion of the
published knowledge. However, we think that a piece of
data that cannot be properly annotated is of limited use
for the community. For instance, a large amount of phar-
macological properties is published without the species.
Since those properties vary from one species to the other,
one cannot easily re-use the value provided. Similarly, a
numerical piece of knowledge cannot be used without
caution if one does not know the method used to collect
it, and the variability attached to it. Currently, the access
to the data is only possible through the web interface.
Moreover, although the user is able to search the content
of the Molecular Pages using various criteria, the result is
always presented as one or several Molecular Pages. How-
ever, the DopaNet Web Service should be enriched on a
steady pace, and specific pieces of data should be served
soon. One can envision interfaces providing precise and
meaningful responses to queries like "All Kd for the ligand
X of all molecules that bind it", under the form of a list of
Kd  In addition, pieces of quantitative knowledge, like
binding or enzymatic reactions, should be provided in
standardized format such as the Systems Biology Markup
Language [26].
The Molecular Pages are maintained in a distributed fash-
ion, with one or several experts in charge of each complex.
Such an approach is mandatory for two reasons. Firstly,
the knowledge accumulated by the project will soon
become much too large to be handled by one individual,
or even one team. Secondly, the level of detail and accu-
racy sought by the resource is such that only experts can
fruitfully mine the adequate literature for relevant infor-
mation. To extract the simple affinity of a receptor for a
ligand can be a daunting prospect. Not only that affinity
can be expressed by various parameters with different
meaning, Ka, Kd, Ki, Kp, IC50, but all those quantities can
only be analyzed in regards of the knowledge about the
various states of the complex, and its conformational tran-
sitions. The distributed annotation can cause concerns
related to peer-validation and quality control. With the
help of Nature Publishing Group, a peer review process
has been set-up by the Alliance for Cellular Signaling to
survey the edition of its Molecule Pages. Such an infra-
structure is currently out of reach of DopaNet. However,
we ensure that the maintainers are always recognized
experts in the fields, or, for members of the EBI group,
work in close relation. In addition, we included as much
as possible guidance through the constraints imposed by
the Page editing environment. That way, any Molecular
Page complies with at least a minimal set of quality rules.
Such an approach has already been successful in other
areas. One of the most striking example is the Debian
operating system project ([27]), that maintains around
9000 software packages for 11 computer architectures,
with the help of about 1000 developers. The project has
been running since 1993, and it is recognized as one of
the most robust operating systems.
On the contrary of the Molecular Pages, the Neuronal
Ontology is currently developed only by the EBI team.
Everyone can contribute by sending their suggestions, but
for the sake of coherence the final building is centralized.
Conclusions
DopaNet Molecular Pages allow to store annotated
numerical data about molecular complexes involved in
neuronal signaling. Although the Pages are one of the core
resources of the DopaNet project, and therefore their
focus on the mesotelencephalic dopamine system, the
repository should be of widespread utility in the field ofPublish with BioMed Central    and   every 
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Systems Neurobiology. This is also the case of The
DopaNet Neuronal Ontology. The resource is in its early
stage of development and will benefit much from the
feedback of users.
Availability and requirements
All data contained in the DopaNet Molecular Pages may
be copied and redistributed freely, under terms derived
from the MIT license [28].
More information about the DopaNet project can be
found at the URL http://www.dopanet.org.
DopaNet ontology is available at the URL http://
www.ebi.ac.uk/compneur-srv/dopanet/ontology.html
DopaNet Molecular Pages are available at the URL
http://www.ebi.ac.uk/compneur-srv/dopanet/mol
pages.html
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